Literature DB >> 20812894

Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon.

Jiangqin Zhao1, Shixing Tang, Viswanath Ragupathy, Jean K Carr, Nathan D Wolfe, Bih Awazi, Indira Hewlett.   

Abstract

Cameroon is a country in West Central Africa in which all four groups of HIV-1 (M, N, O, and P), some circulating recombinant forms (CRFs) and unique recombinant forms (URFs) are prevalent. The CRF22 was initially identified through a novel URF strain, 01CM53122, and later defined from two additional sequences; however, the genomic properties of CRF22 have never been demonstrated in detail. In this study, we describe the characterization of five CRF22_01A1 strains, 02CMLT72, 01CM1867LE, 01CM001BBY, 02CM3097MN, and 02CM1917LE, identified in Cameroon without apparent epidemiological links. A typical CRF22_01A1 strain contains five fragments that can be assigned to the CRF01_AE and subsubtype A1 radiations. Forty-eight percent of the genome is classified as CRF01_AE, spanning the entire region of the gag gene, part of the pol gene, and accessory genes as well as the beginning and the end of the env gene and nef gene. Fifty-two percent of the genome is subsubtype A1 including regions mostly in the pol, vif, and env genes. The five CRF22_01A1 viruses formed a deep branch outside the groups of CRF01_AE and displayed similar mosaic structure but were moderately different from the original strain of CRF22_01A1, 01CM53122. Further analysis of the 01CM53122 genome showed that this virus represents a diverse set of mosaic genomes from CRF22_01A1, including a 446-nt segment of 01CM53122 in the env region, but unlike other CRF22 strains, clustered with CRF01_AE rather than the A1 sequence, suggesting that the 01CM53122 strain is a recombinant of CRF22_01A1 and CRF01_AE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812894      PMCID: PMC2931544          DOI: 10.1089/aid.2009.0197

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  42 in total

1.  Characterization of subtype A HIV-1 from Africa by full genome sequencing.

Authors:  J K Carr; T Laukkanen; M O Salminen; J Albert; A Alaeus; B Kim; E Sanders-Buell; D L Birx; F E McCutchan
Journal:  AIDS       Date:  1999-10-01       Impact factor: 4.177

2.  HIV-1 nomenclature proposal.

Authors:  D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

3.  HIV genetic diversity in Cameroon: possible public health importance.

Authors:  Clement B Ndongmo; Danuta Pieniazek; Mona Holberg-Petersen; Carol Holm-Hansen; Leopold Zekeng; Stig L Jeansson; Lazare Kaptue; Marcia L Kalish
Journal:  AIDS Res Hum Retroviruses       Date:  2006-08       Impact factor: 2.205

4.  A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences.

Authors:  A C Siepel; A L Halpern; C Macken; B T Korber
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

5.  Increase of HIV-1 subtype A in Central African Republic.

Authors:  M C Müller-Trutwin; M L Chaix; F Letourneur; E Bégaud; D Beaumont; A Deslandres; B You; J Morvan; C Mathiot; F Barré-Sinoussi; S Saragosti
Journal:  J Acquir Immune Defic Syndr       Date:  1999-06-01       Impact factor: 3.731

6.  Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Authors:  N Vidal; M Peeters; C Mulanga-Kabeya; N Nzilambi; D Robertson; W Ilunga; H Sema; K Tshimanga; B Bongo; E Delaporte
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E.

Authors:  J P Anderson; A G Rodrigo; G H Learn; A Madan; C Delahunty; M Coon; M Girard; S Osmanov; L Hood; J I Mullins
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Emergence of new forms of human immunodeficiency virus type 1 intersubtype recombinants in central Myanmar.

Authors:  K Motomura; S Kusagawa; K Kato; K Nohtomi; H H Lwin; K M Tun; M Thwe; K Y Oo; S Lwin; O Kyaw; M Zaw; Y Nagai; Y Takebe
Journal:  AIDS Res Hum Retroviruses       Date:  2000-11-20       Impact factor: 2.205

9.  Human immunodeficiency viruses: SIV infection in wild gorillas.

Authors:  Fran Van Heuverswyn; Yingying Li; Cecile Neel; Elizabeth Bailes; Brandon F Keele; Weimin Liu; Severin Loul; Christelle Butel; Florian Liegeois; Yanga Bienvenue; Eitel Mpoudi Ngolle; Paul M Sharp; George M Shaw; Eric Delaporte; Beatrice H Hahn; Martine Peeters
Journal:  Nature       Date:  2006-11-09       Impact factor: 49.962

10.  Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants.

Authors:  J K Carr; M O Salminen; J Albert; E Sanders-Buell; D Gotte; D L Birx; F E McCutchan
Journal:  Virology       Date:  1998-07-20       Impact factor: 3.616

View more
  8 in total

1.  CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon.

Authors:  Jiangqin Zhao; Shixing Tang; Viswanath Ragupathy; Durga Gaddam; Xue Wang; Panhe Zhang; Phillipe N Nyambi; Indira Hewlett
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

2.  Seroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in Cameroon.

Authors:  Christelle Mbondji-Wonje; Viswanath Ragupathy; Sherwin Lee; Owen Wood; Bih Awazi; Indira K Hewlett
Journal:  Viruses       Date:  2013-09-19       Impact factor: 5.048

3.  Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.

Authors:  Viswanath Ragupathy; Jiangqin Zhao; Owen Wood; Shixing Tang; Sherwin Lee; Phillipe Nyambi; Indira Hewlett
Journal:  Virol J       Date:  2011-04-23       Impact factor: 4.099

4.  Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management.

Authors:  Sebastian Grossmann; Piotr Nowak; Ujjwal Neogi
Journal:  J Int AIDS Soc       Date:  2015-06-25       Impact factor: 5.396

5.  Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.

Authors:  Georges Teto; Julius Y Fonsah; Claude T Tagny; Dora Mbanya; Emilienne Nchindap; Leopoldine Kenmogne; Joseph Fokam; Dora M Njamnshi; Charles Kouanfack; Alfred K Njamnshi; Georgette D Kanmogne
Journal:  Viruses       Date:  2016-07-18       Impact factor: 5.048

6.  Correction: Recombination Pattern Reanalysis of Some HIV-1 Circulating Recombination Forms Suggest the Necessity and Difficulty of Revision.

Authors:  Lei Jia; Lin Li; Hanping Li; Siyang Liu; Xiaolin Wang; Zuoyi Bao; Tianyi Li; Daomin Zhuang; Yongjian Liu; Jingyun Li
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

7.  Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Xue Wang; Jiangqin Zhao; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

8.  A high HIV-1 strain variability in London, UK, revealed by full-genome analysis: Results from the ICONIC project.

Authors:  Gonzalo Yebra; Dan Frampton; Tiziano Gallo Cassarino; Jade Raffle; Jonathan Hubb; R Bridget Ferns; Laura Waters; C Y William Tong; Zisis Kozlakidis; Andrew Hayward; Paul Kellam; Deenan Pillay; Duncan Clark; Eleni Nastouli; Andrew J Leigh Brown
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.